Primary Lymphedema Clinical Trial
Official title:
Out-of Pocket Payments in Patients With Primary Lymphedema in France and Inequities of Access to Healthcare
Primary lymphedema is a chronic condition posing a high burden on patients. Clinical
guidelines emphasize the role of compression therapy by prescription medical devices. Even in
a mandatory publicly funded health insurance system, out-of-pocket payments (OOPP) may exist
due to the price and reimbursement setting processes. OOPP may threaten the equity of care
and drive patients to forgo care. The investigators aim was to analyze the distributive
effects of OOPP for primary lymphedema patients in France.
A prospective, multicenter study will be conducted in France in 2015 on patients with primary
lymphedema. Household ability to pay will be specified by net income and OOPP will be
assessed prospectively over 6 months for outpatient care (visits, drugs, medical devices,
nursing care, biological tests, imaging, physiotherapy and transportations). Both mandatory
and voluntary health insurance reimbursements will be considered. The investigators will
combine concentration curves and concentration indices to assess the distributive effects.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02595996 -
Propranolol Dose Escalation in Lymphedema in Patients
|
Phase 2 | |
| Completed |
NCT01748604 -
Physical Therapies in the Decongestive Treatment of Lymphedema
|
N/A | |
| Recruiting |
NCT04919655 -
Primary Lymphedema and Mutation CELSR1 (Cadherin EGF LAG Seven-pass G-type Receptor 1)
|
||
| Not yet recruiting |
NCT06327412 -
The Effects of Aerobic Exercise in Patients With Primary Lower Extremity Lymphedema
|
N/A |